Indivior Pharmaceuticals (INDV) Revenue Growth (1y) (2025 - 2026)

Indivior Pharmaceuticals (INDV) Revenue Growth (1y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (1y) (Qtr)
1 Haleon 89.42 Bn 87.55 Bn - -
2 Teva Pharmaceutical Industries 35.91 Bn 32.16 Bn 1.97 Bn 2.34%
3 Zoetis 32.72 Bn 30.78 Bn 1.62 Bn 2.91%
4 Takeda Pharmaceutical 27.65 Bn 23.59 Bn 4.39 Bn -11.85%
5 United Therapeutics 23.11 Bn 20.96 Bn 648.10 Mn -1.62%
6 RedHill Biopharma 21.80 Bn 21.80 Bn - -
7 Viatris 20.30 Bn 18.50 Bn 1.16 Bn 7.85%
8 Neurocrine Biosciences 17.88 Bn 16.56 Bn 800.70 Mn 42.25%
9 Elanco Animal Health 12.65 Bn 12.22 Bn 785.00 Mn 14.92%
10 Indivior Pharmaceuticals 5.01 Bn 4.84 Bn 277.00 Mn 19.17%

Historic Data

Download Data
DateValue
Mar 31, 2026 19.17%
Dec 31, 2025 19.73%
Sep 30, 2025 2.28%
Jun 30, 2025 1.00%
Mar 31, 2025 -6.34%